SEC Form 3 · accession 0000899243-17-019736
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Kirske
Officer — See Remarks
Period of report
Aug 1, 2017
Accepted (ET)
Aug 3, 2017 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par value per share | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
principal financial and accounting officer Exhibit Index Exhibit 24 - Power of Attorney